Cargando…
Locoregional therapies in patients with recurrent intrahepatic cholangiocarcinoma after curative resection
BACKGROUND: Hepatectomy is one potential treatment for intrahepatic cholangiocarcinoma (IHCC). Recurrent rate is high after curative resection and most recurrences occur within residual liver parenchyma. The aim of this study was to elucidate the impact of different treatment modalities on recurrent...
Autores principales: | Liu, Hsiao-Tien, Cheng, Shao-Bin, Lai, Chia-Yu, Chen, Yi-Ju, Su, Te-Cheng, Wu, Cheng-Chung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7734491/ https://www.ncbi.nlm.nih.gov/pubmed/33354228 http://dx.doi.org/10.1177/1756284820976974 |
Ejemplares similares
-
Survival benefits from adjuvant transcatheter arterial chemoembolization in patients undergoing liver resection for hepatocellular carcinoma: a systematic review and meta-analysis
por: Liang, Lei, et al.
Publicado: (2020) -
Comparing the efficacy and safety of second-line therapies for advanced hepatocellular carcinoma: a network meta-analysis of phase III trials
por: Wang, Dongxu, et al.
Publicado: (2020) -
Pattern of progression of intrahepatic cholangiocarcinoma: Implications for second‐line clinical trials
por: Tovoli, Francesco, et al.
Publicado: (2021) -
DKK1 drives immune suppressive phenotypes in intrahepatic cholangiocarcinoma and can be targeted with anti‐DKK1 therapeutic DKN‐01
por: Jarman, Edward J., et al.
Publicado: (2022) -
Stronger implicit interference in cognitively healthy older participants with higher risk of Alzheimer's disease
por: Hung, Shao‐Min, et al.
Publicado: (2022)